Decline depth
-67.3%
From rolling 252-day high of $25.95, 69d ago.
Past the 40% Red List threshold.
Red List
BIOABioAge Labs, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic · small-cap ($477M)
-67.3%
from rolling 252-day high of $25.95 set 2026-07-06 · 69d ago
Current
$8.49
Decline depth
-67.3%
Decline σ
6.6σ
TFC
3/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$BIOA landed on the list 2026-03-14, down 10.2% from its 52-week high that day — now down -67.3%.
That's 54.4 percentage points deeper than the day it joined.
From the 52-week high as of 2026-03-16 to today. Split-adjusted. Observed, not a forecast.
Structural break signals
BIOA qualifies for the Red List on decline depth.
Time-frame continuity
3/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Past the 3/5 Watch threshold.
Decline sigma
6.6σ
Drop over the last 20 bars in units of daily volatility (3.63%/day).
Past the ≥6σ Amber threshold.
The structural read
What price action says about BIOA.
BIOA qualifies for the Red List on decline depth — down -67.3% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy. Depth plus recency: this is the pattern many investors call a falling knife.
Cross-confirmation: also showing 3/5 bearish time frames.
Cross-confirmation: decline sigma also reads 6.6σ over 20 bars.
Earnings on file: 2026-05-08. Earnings dates don't affect tiering.
Questions about BIOA
What people ask.
Why is BIOA on Broken Stocks?
BIOA qualifies for the Red List on decline depth. It is down -67.3% from its rolling 252-day high of $25.95, set on 2026-07-06 — 69d ago.
Is BIOA a falling knife?
By the most common technical definition — a steep, recent breakdown from a fresh high — yes. BIOA is down -67.3% from its 52-week high of $25.95, set 69d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.
Is BIOA a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is BIOA trading inside its 52-week range?
At $8.49, BIOA sits 19.0% of the way from its 52-week low ($4.38) to its 52-week high ($25.95). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has BIOA been declining?
The current 67.3% decline accrued over 69d, which annualizes to roughly -356.0% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does BIOA compare to its sector?
There are 267 other Healthcare tickers on Broken Stocks: 146 Red, 82 Amber, 39 Watch, with 27 showing recovering structural signals. Median sector decline is -36.7% — BIOA's decline is deeper than the sector median.
Does BIOA's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-08) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.